Guoshu Bi Selected Research

Guoshu Bi Research Topics

Disease

32	Neoplasms (Cancer) 03/2024 - 01/2019
14	Adenocarcinoma of Lung 02/2024 - 01/2020
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2023 - 01/2020
3	Esophageal Squamous Cell Carcinoma 12/2023 - 10/2021
3	Carcinogenesis 12/2023 - 01/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 12/2021
2	Carcinoma (Carcinomatosis) 08/2023 - 12/2019
1	Iron Overload 03/2024
1	Residual Neoplasm 02/2024
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Adenocarcinoma 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

7	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
6	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2020
5	IronIBA 03/2024 - 01/2021
5	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 06/2022
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2020
3	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 12/2019
2	Transcription Factors (Transcription Factor)IBA 02/2024 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 02/2024 - 08/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 10/2021
2	LigandsIBA 08/2023 - 01/2020
2	PlatinumIBA 11/2022 - 10/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2020
2	Small Cytoplasmic RNAIBA 01/2020 - 01/2020
1	PolyaminesIBA 03/2024
1	EnzymesIBA 03/2024
1	Lipid PeroxidesIBA 03/2024
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 03/2024
1	osimertinibIBA 02/2024
1	Tyrosine Kinase InhibitorsIBA 02/2024
1	Basic-Leucine Zipper Transcription FactorsIBA 01/2024
1	CobaltIBA 12/2023
1	Sincalide FDA Link 12/2023
1	imidazole ketone erastinIBA 11/2023
1	N-methyladenosineIBA 08/2023
1	6-methyladenineIBA 08/2023
1	Cancer VaccinesIBA 07/2023
1	Immune Checkpoint InhibitorsIBA 07/2023
1	RetinoidsIBA 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	Vitamin A (Retinol)FDA LinkGeneric 01/2023
1	N 563IBA 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2023
1	AntibodiesIBA 01/2023
1	CytokinesIBA 12/2022
1	Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA 12/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2022
1	Interleukin-10 (Interleukin 10)IBA 12/2022
1	Metformin (Glucophage)FDA LinkGeneric 07/2022
1	atezolizumabIBA 07/2022
1	Pemetrexed (MTA)FDA Link 06/2022
1	NucleotidesIBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2021
1	Messenger RNA (mRNA)IBA 03/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	OsteopontinIBA 01/2020
1	SuspensionsIBA 01/2020
1	Pyruvic Acid (Pyruvate)IBA 12/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2019
1	Citric Acid (Citrate)FDA LinkGeneric 12/2019

Therapy/Procedure

9	Therapeutics 03/2024 - 01/2020
7	Drug Therapy (Chemotherapy) 03/2024 - 01/2019
6	Immunotherapy 07/2023 - 01/2020
1	Radiotherapy 03/2024
1	Chemoradiotherapy 12/2023
1	Aftercare (After-Treatment) 01/2023